Nemera has acquired a healthcare focused design and innovation consulting firm in Chicago, IL, Insight Product Development, strengthening its presence in North America.
Drug delivery device specialist, Nemera, has acquired a healthcare focused design and innovation consulting firm in Chicago, IL, Insight Product Development, strengthening its presence in North America.
In an Aug. 8, 2019 press release, the company announced that the latest acquisition will complement its existing design centre, located in La Verpillière in France. Additionally, Insight’s base, which is close to Nemera’s manufacturing facility (Buffalo Grove, IL), will strengthen the development footprint of the company in North America and will improve its proximity to the US customer base.
“Insight’s expertise of understanding patient needs and translating that into impactful product designs aligns perfectly with our purpose to ‘put patients first’,” said Marc Hämel, Nemera’s CEO, in the press release. “This acquisition strengthens our engagement to take patients’ needs into account at every stage of product development cycle and to guarantee the best match with their needs.”
“Insight is very honored to be joining Nemera, a world class leader in the innovation and manufacture of so many impressive drug delivery systems,” added Craig Scherer, Insight product development’s co-founder. “Bolstering Nemera’s front end offerings in user research and design, Insight is very pleased to help Nemera provide exceptional capabilities to their clients from innovation through industrialization.”
Source: Nemera
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.